Elizabeth Buck
CHIEF SCIENTIFIC OFFICER · Black Diamond Therapeutics, Inc.
Individual
- 2026
- Jan 23, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Elizabeth Buck's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Keith A. Meister - $74.03M in WGS purchases and sales in the last 12 months
- Warren B. Kanders - $73.88M in CDRE purchases and sales in the last 12 months
- Amirali Talasaz - $73.75M in GH purchases and sales in the last 12 months
- L1 Capital Pty Ltd - $72.66M in AVR purchases and sales in the last 12 months
- James E. Flynn - $70.87M in NUVL purchases and sales in the last 12 months
- Joaquin Duato - $66.84M in JNJ purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Elizabeth Buck?
Elizabeth Buck is a corporate insider, tracked as CHIEF SCIENTIFIC OFFICER of Black Diamond Therapeutics, Inc. (BDTX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Elizabeth Buck last file a Form 4?
The only primary Form 4 on record is dated 23 January 2026.